Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,372
Closed -$270K 52
2024
Q1
$270K Sell
2,372
-2,597
-52% -$298K 0.11% 67
2023
Q4
$547K Sell
4,969
-507
-9% -$50.7K 0.2% 67
2023
Q3
$530K Sell
5,476
-709
-11% -$74.5K 0.24% 51
2023
Q2
$674K Buy
6,185
+1,511
+32% +$161K 0.29% 48
2023
Q1
$473K Sell
4,674
-144
-3% -$15.2K 0.22% 54
2022
Q4
$529K Sell
4,818
-247
-5% -$25.6K 0.26% 53
2022
Q3
$490K Buy
5,065
+712
+16% +$75.9K 0.25% 93
2022
Q2
$473K Buy
4,353
+449
+12% +$51K 0.2% 112
2022
Q1
$462K Sell
3,904
-1,847
-32% -$229K 0.16% 128
2021
Q4
$810K Buy
5,751
+3,145
+121% +$403K 0.24% 104
2021
Q3
$308K Buy
2,606
+9
+0.3% +$1.11K 0.12% 183
2021
Q2
$301K Sell
2,597
-14,980
-85% -$1.75M 0.17% 155
2021
Q1
$2.11M Buy
17,577
+12,154
+224% +$1.44M 1.23% 7
2020
Q4
$594K Buy
+5,423
New +$589K 0.35% 91

Other funds holding ABT

DCM Advisors's ABT Position: Q2 2024 in Review

DCM Advisors sold out of Abbott (ABT) in Q2 2024, closing a stake of 2,372 shares — an estimated $270K sold.

DCM Advisors first reported a position in ABT in Q4 2020 and held it in 14 quarters. The position peaked at $2.11M in Q1 2021. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • DCM Advisors reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • DCM Advisors sold 2,372 Abbott shares in Q2 2024, an estimated $270K.
  • DCM Advisors first reported a position in Abbott in Q4 2020 and held it in 14 quarters.
  • DCM Advisors's Abbott position peaked at $2.11M in Q1 2021.
  • 2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on DCM Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.